KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBT Margin (2016 - 2025)

Medpace Holdings (MEDP) has disclosed EBT Margin for 11 consecutive years, with 22.14% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 281.0% year-over-year to 22.14%, compared with a TTM value of 76.56% through Dec 2025, up 5399.0%, and an annual FY2025 reading of 21.44%, down 113.0% over the prior year.
  • EBT Margin was 22.14% for Q4 2025 at Medpace Holdings, down from 24.95% in the prior quarter.
  • Across five years, EBT Margin topped out at 24.95% in Q4 2024 and bottomed at 15.24% in Q2 2021.
  • Average EBT Margin over 5 years is 19.49%, with a median of 18.69% recorded in 2022.
  • The sharpest move saw EBT Margin crashed -445bps in 2023, then soared 675bps in 2024.
  • Year by year, EBT Margin stood at 18.12% in 2021, then grew by 3bps to 18.69% in 2022, then decreased by -3bps to 18.2% in 2023, then surged by 37bps to 24.95% in 2024, then decreased by -11bps to 22.14% in 2025.
  • Business Quant data shows EBT Margin for MEDP at 22.14% in Q4 2025, 24.95% in Q4 2024, and 22.27% in Q3 2024.